These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18840013)

  • 1. Effects of an oral contraceptive containing chlormadinone and ethinylestradiol on acne-prone skin of women of different age groups: an open-label, single-centre, phase IV study.
    Kerscher M; Reuther T; Bayrhammer J; Schramm G
    Clin Drug Investig; 2008; 28(11):703-11. PubMed ID: 18840013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month evaluation of the benefits of the low-dose combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg in young women: results of the prospective, observational, non-interventional, multicentre TeeNIS study.
    Anthuber S; Schramm GA; Heskamp ML
    Clin Drug Investig; 2010; 30(4):211-20. PubMed ID: 20225905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the new antiandrogenic oral contraceptive Belara.
    Zahradnik HP; Goldberg J; Andreas JO
    Contraception; 1998 Feb; 57(2):103-9. PubMed ID: 9589837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
    Vartiainen M; de Gezelle H; Broekmeulen CJ
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon).
    Worret I; Arp W; Zahradnik HP; Andreas JO; Binder N
    Dermatology; 2001; 203(1):38-44. PubMed ID: 11549798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
    Brucker C; Hedon B; The HS; Höschen K; Binder N; Christoph A
    Contraception; 2010 Jun; 81(6):501-9. PubMed ID: 20472117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G; Cunliffe WJ; Binder N; Höschen K
    Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice.
    Pushparajah DS; Röhm P; Höschen K; Albers D; Nowack C
    Clin Drug Investig; 2011; 31(2):121-34. PubMed ID: 21155614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
    Uras R; Orrù M; Pani F; Marotto MF; Pilloni M; Guerriero S; Etzi R; Zedda P; Sorge R; Lello S; Melis GB; Paoletti AM
    Contraception; 2010 Aug; 82(2):131-8. PubMed ID: 20654753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception.
    Kerscher M; Reuther T; Krueger N; Buntrock H
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):601-8. PubMed ID: 22404700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg.
    Hadji P; Biskup J; Boekhoff J; Ziller M; Bonn M; Rovati L
    Contraception; 2012 Oct; 86(4):359-65. PubMed ID: 22445436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne.
    Prilepskaya VN; Serov VN; Zharov EV; Golousenko IJ; Mejevitinova EA; Gogaeva EV; Yaglov VV; Golubeva ON
    Contraception; 2003 Oct; 68(4):239-45. PubMed ID: 14572886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Belara--proven benefits in daily practice.
    Bitzer J
    Eur J Contracept Reprod Health Care; 2005; 10 Suppl 1():19-25. PubMed ID: 16356878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.
    Caruso S; Rugolo S; Agnello C; Romano M; Cianci A
    J Sex Med; 2009 Dec; 6(12):3376-84. PubMed ID: 19832931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
    Yildizhan R; Gokce AI; Yildizhan B; Cim N
    Gynecol Endocrinol; 2015 May; 31(5):396-400. PubMed ID: 25739031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits.
    Heskamp ML; Schramm GA
    Contraception; 2010 Jan; 81(1):49-56. PubMed ID: 20004273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
    Fenton C; Wellington K; Moen MD; Robinson DM
    Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.